![]() |
Dr. Jorgen Dirach
|
Jorgen Dirach, MD, MBA, is Director of Corporate Research Affairs at Novo Nordisk A/S in Copenhagen, Denmark. Dr. Dirach has worked as a physician at hospitals and thereafter done clinical development and project management in the pharmaceutical industry for 15 years. >From 1995 to 2002 he was instrumental in the transformation of the management of the portfolio of drug development projects in Novo Nordisk from a divisionalised structure to a true portfolio management view. He is honorary member of the Danish Society for Good Clinical Practice, which he started in 1988 and served as Chairman for 1988 to 1996. He is a member of the Faculty of Pharmaceutical Physicians (UK), Chairman of the Section on Medicines Development under the auspices of the European Federation of Biotechnology (EFB), and serves as Governor on the Board of the European Association of Pharma Biotechnology. Dr. Dirach has authored publications and delivered lectures on clinical research methodology, pharmacokinetics, good clinical practice (GCP), drug development/multi project management and quality management.
Updated: by Andriy Levytskyy
Copyright © European Federation of Biotechnology